Optimized dosing with anti-CD4 antibodies for tolerance induction in primates

Details for Australian Patent Application No. 2005258276 (hide)

Owner TolerRx, Inc.

Inventors Rao, Patricia; Ringler, Douglas J.; Ponath, Paul; Winsor-Hines, Dawn

Agent FB Rice

Pub. Number AU-A-2005258276

PCT Pub. Number WO2006/002377

Priority 60/582,181 22.06.04 US

Filing date 21 June 2005

Wipo publication date 5 January 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2006/002377 Priority application(s): WO2006/002377

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005258280-Neoglycorandomization and digitoxin analogs

2005258274-Method of treating ileus by pharmacological activation of cholinergic receptors